- Home
- ADMA vs PHI Comparison
ADMA vs PHI Comparison
Compare ADMA & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- PHI
- Stock Information
- Founded
- ADMA 2004
- PHI 1928
- Country
- ADMA United States
- PHI Philippines
- Employees
- ADMA N/A
- PHI N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- PHI Telecommunications Equipment
- Sector
- ADMA Health Care
- PHI Telecommunications
- Exchange
- ADMA Nasdaq
- PHI Nasdaq
- Market Cap
- ADMA 5.1B
- PHI 4.8B
- IPO Year
- ADMA N/A
- PHI 1953
- Fundamental
- Price
- ADMA $17.74
- PHI $21.68
- Analyst Decision
- ADMA Strong Buy
- PHI
- Analyst Count
- ADMA 4
- PHI 0
- Target Price
- ADMA $24.25
- PHI N/A
- AVG Volume (30 Days)
- ADMA 2.7M
- PHI 58.3K
- Earning Date
- ADMA 08-07-2025
- PHI 08-12-2025
- Dividend Yield
- ADMA N/A
- PHI 7.88%
- EPS Growth
- ADMA N/A
- PHI 14.93
- EPS
- ADMA 0.84
- PHI 2.54
- Revenue
- ADMA $459,381,000.00
- PHI $3,804,539,911.00
- Revenue This Year
- ADMA $23.35
- PHI $3.85
- Revenue Next Year
- ADMA $27.67
- PHI $2.33
- P/E Ratio
- ADMA $21.27
- PHI $8.44
- Revenue Growth
- ADMA 62.23
- PHI 2.38
- 52 Week Low
- ADMA $10.21
- PHI $20.29
- 52 Week High
- ADMA $25.67
- PHI $29.05
- Technical
- Relative Strength Index (RSI)
- ADMA 32.83
- PHI 37.30
- Support Level
- ADMA $20.42
- PHI $21.48
- Resistance Level
- ADMA $22.37
- PHI $22.09
- Average True Range (ATR)
- ADMA 0.88
- PHI 0.37
- MACD
- ADMA -0.28
- PHI -0.07
- Stochastic Oscillator
- ADMA 1.07
- PHI 12.90
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.